From the Literature

Published: Jul 2001

Kormann J, Ockert D, Bunk A

Radiofrequency ablation of liver tumours.
Zbl Chir 2001;126(8):576-585.

#

NATA REVIEW:
Dr. Kormann and colleagues have reviewed the literature on the use of radiofrequency ablation...
REVIEW by:
R. K. Spence

Published: Jul 2001

Meloni MF, Goldberg SN, Livraghi T, et al.

Hepatocellular carcinoma treated with radiofrequency ablation: Comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Am J Roentgenol 2001;177(2):375-380.

#

NATA REVIEW:
Hepatitis C virus infects millions of people worldwide. As the world's population ages, the...
REVIEW by:
R. K. Spence

Published: Jul 2001

Challine D, RoudotThoraval F, Sarah T, et al.

Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.
Transfusion 2001;41(9):1120-1125.

#

NATA REVIEW:
HHV-8 is a pathogenic virus. However, it is still unclear whether HHV-8 can be transmitted...
REVIEW by:
V. Kretschmer.

Published: Jul 2001

Marfin AA, Liu H, Sutton MY, Steiner B, Pillay A, Markowitz LE

Amplification of the DNA polymerase I gene of Treponema pallidum from whole blood of persons with syphilis.
Diagn Microbiol Infect Dis 2001;40(4):163-166.

#

NATA REVIEW:
The article confirms by means of the sensitive PCR technique that Treponema pallidum may be...
REVIEW by:
Kretschmer V.

Published: Jul 2001

Laurent C, Henzel D, MulangaKabeya C, Maertens G, Larouze B, Delaporte E

Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo.
Int J Epidemiol 2001;30(4):872-877.

#

NATA REVIEW:
The article is of some interest in view of the contamination of commercial sex workers and...
REVIEW by:
V. Kretschmer.

Published: Jul 2001

Greenough A

The role of immunoglobulins in neonatal rhesus haemolytic disease.
BioDrugs 2001;15(8):533-541.

#

NATA REVIEW:
Note: Consensus Conference at RCP Edinburgh on anti-D did NOT state that one dose of 1000...
REVIEW by:

Published: Jul 2001

Jurlander B, Thim L, Klausen NK, et al.

Recombinant activated factor VII (RFVIIa): Characterization, manufacturing, and clinical development.
Semin Thromb Hemostasis 2001;27(4):373-383.

#

NATA REVIEW:
A good overall review on the characterization, mechanism of action, and preclinical and...
REVIEW by:
M. Aldouri

Published: Jul 2001

Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D

Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Bone Marrow Transplant 2001;28(4):405-407.

#

NATA REVIEW:
This is a report on off-label extended use of rFVIIa in managing pulmonary, vesical and GI...
REVIEW by:
M. Aldouri

Published: Jul 2001

Frere MC, Rapaille A, Bouillenne C, Gerard C, Sondag D, Verhees A

Analysis of 516 reaction reports after transfusion of blood cell components.
Transfus Clin Biol 2001;8(4):333-342.

#

NATA REVIEW:
The article gives data on transfusion reactions that are not conclusive. There is no doubt...
REVIEW by:
Kretschmer V.

Published: Jul 2001

Erhardtsen E, Nilsson P, Johannessen M, Thomsen MS

Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects.
J Clin Pharmacol 2001;41(8):880-885.

#

NATA REVIEW:
This is a double-blind placebo controlled dose escalation trial evaluating efficacy and safety...
REVIEW by:
M. Aldouri; J. Ingerslev

Pages